Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 12,335 | 4,838 | 6,714 | 4,305 | 7,526 |
| Cost of Goods | 1,917 | 2,183 | 2,924 | 1,554 | 6,066 |
| Gross Profit | 10,418 | 2,655 | 3,790 | 2,751 | 1,460 |
| Operating Expenses | 15,076 | 9,582 | 9,865 | 12,887 | 9,291 |
| Operating Income | -3,741 | -6,744 | -5,151 | -9,582 | -7,765 |
| Other Income | -1,581 | -1,718 | -2,088 | -3,723 | -3,672 |
| Pre-tax Income | -5,322 | -8,462 | -7,239 | -13,305 | -11,437 |
| Net Income Continuous | -5,322 | -8,462 | -7,239 | -13,305 | -11,437 |
| Net Income | $-5,322 | $-8,462 | $-7,239 | $-13,305 | $-11,437 |
| EPS Basic Total Ops | -0.40 | -0.60 | -0.50 | -0.67 | -0.90 |
| EPS Basic Continuous Ops | -0.36 | -0.58 | -0.50 | -0.79 | -0.86 |
| EPS Diluted Total Ops | -0.40 | -0.60 | -0.50 | -0.07 | -0.90 |
| EPS Diluted Continuous Ops | -0.36 | -0.58 | -0.50 | -0.77 | -0.86 |
| EBITDA(a) | $-2,671 | $-5,690 | $-4,102 | $-8,507 | $-6,713 |